Enzymatica AB: Enzymatica announces outcome of new rights issue
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, SOUTH AFRICA OR AUST...
Below you will find current and archived press releases for your associated company. Navigate by selecting the year in the list below and click on the press release you want to read. Distribution takes place with a maximum of five minutes delay from press release.
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, SOUTH AFRICA OR AUST...
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, SOUTH AFRICA OR AUST...
A new study by the Medical University of Innsbruck (MUI) shows that ColdZyme protects airway epithelia from infection with the widespread omicron ...
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, SOUTH AFRICA OR AUST...
Significant Significant events after the quarter
events in
Q2In · To secure long-time financing of the operations, the Board ofJune, ...
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, SOUTH AFRICA OR AUST...
23 June 2022
Regulatory press release
ColdZyme blocks omicron virus - according to new research
New data from an ongoing in-vitro study s...
16 June 2022
Regulatory press release
Enzymatica signs loan agreement with major shareholders
Enzymatica AB has signed a two-year loan ag...
28 April 2022
Bulletin from Annual General Meeting of Enzymatica AB (publ) on 28 April 2022
The English text is an unofficial translation. I...
28 april 2022
Kommuniké från årsstämma i Enzymatica AB (publ) den28april 2022
Enzymatica AB (publ) höll den 28 april 2022 årsstämma. Vid stä...
Significant Significant events after the quarter
events in
Q1In · In April, Enzymatica announced that its mouth spray would beMarch, ...
11 April 2022
Non-regulatory press release
Article about ColdZyme acquitted from
suspicions of research misconduct
The Swedish National ...
4 April 2022
Non-regulatory press release
Enzymatica's mouth spray to be launched in Turkey
Enzymatica's mouth spray against the common c...
31 March 2022
Regulatory press release
Enzymatica publishes annual report for 2021
The annual report for Enzymatica 2021 has today been p...
Press release
Lund, 28 March 2022
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and t...
Enzymatica and Sanofi Consumer Health Care, part of the French pharmaceutical group Sanofi, have expanded their current agreement for marketing, d...
Significant Other events in Q4
events in Q4The · Enzymatica's partner Sanofi received approval from theExtraordinary health...
Under 2021 gjorde Enzymatica framsteg på flera fronter, exempelvis stärktes både organisationen och bolagets finansiella ställning vilket gör att ...
The headline and introduction of an article today on the webpage of the Swedish magazine Dagens Medicin wrongfully claim that a study on ColdZyme®...